Medinova Diagnostic Services Limited

BSE:526301 Stock Report

Market Cap: ₹412.0m

Medinova Diagnostic Services Past Earnings Performance

Past criteria checks 2/6

Medinova Diagnostic Services has been growing earnings at an average annual rate of 16.8%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been growing at an average rate of 1.8% per year.

Key information

16.8%

Earnings growth rate

17.0%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate1.8%
Return on equityn/a
Net Margin19.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medinova Diagnostic Services makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:526301 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24991960
30 Jun 241022100
31 Mar 241022060
31 Dec 231042250
30 Sep 231032050
30 Jun 23991700
31 Mar 231001750
31 Dec 22991220
30 Sep 221031420
30 Jun 221111520
31 Mar 221322320
31 Dec 211332520
30 Sep 211443020
30 Jun 211573120
31 Mar 211272020
31 Dec 201191620
30 Sep 2099720
30 Jun 2071-200
31 Mar 2074-320
31 Dec 19791030
30 Sep 1981730
30 Jun 1988900
31 Mar 1990830
31 Dec 1890460
30 Sep 1893460
30 Jun 1890300
31 Mar 1887-560
31 Dec 1784-650
30 Sep 1782-1350
30 Jun 1780-1550
31 Mar 1778-1780
31 Dec 1690-2760
30 Sep 1693-2560
30 Jun 1691-2000
31 Mar 1681-1960
31 Dec 1572-3860
30 Sep 1567-3360
30 Jun 1570-3660
31 Mar 1577-3660
31 Dec 1483-94512
30 Sep 1494-74512
30 Jun 14101-300
31 Mar 1411104512
31 Dec 13123-25012

Quality Earnings: 526301 has high quality earnings.

Growing Profit Margin: 526301's current net profit margins (19.4%) are lower than last year (19.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 526301's earnings have grown by 16.8% per year over the past 5 years.

Accelerating Growth: 526301's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 526301 had negative earnings growth (-4.1%) over the past year, making it difficult to compare to the Healthcare industry average (29.6%).


Return on Equity

High ROE: 526301's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies